qRT-PCR and western blot analyses of serum samples collected from SSc patients and healthy controls suggested that miR-16-5p was downregulated and NOTCH2 was upregulated in SSc patients (Figure 7A–7B and Supplementary Figures 5 and 6). This evidence concerns the gene NOTCH2 and systemic sclerosis.